Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PTrana Meditama Metropolitan Tbk Days Payable?
PTrana Meditama Metropolitan TbkISX:SAME -0.65%79 Days Payable is 53.50 as of Mar. 2026, which is 3% above its 10-year median of 51.90. GuruFocus rates ISX:SAME with a GF Score™ of 79/100 and a GF Value™ of Rp355.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 608 Healthcare Providers & Services companies, PTrana Meditama Metropolitan Tbk ranks worse than 56.09% on this metric.
The historical rank and industry rank for PTrana Meditama Metropolitan Tbk's Days Payable or its related term are showing as below:
ISX:SAME'
s Days Payable Range Over the Past 10 Years
Min: 33.41 Med: 51.9 Max: 95.1
Current: 50.71
During the past 13 years, PTrana Meditama Metropolitan Tbk's highest Days Payable was 95.10. The lowest was 33.41. And the median was 51.90.
ISX:SAME's Days Payable is ranked worse than 56.09% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 57.32
vs ISX:SAME: 50.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk Days Payable Chart
ISX:SAME vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, PTrana Meditama Metropolitan Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTrana Meditama Metropolitan Tbk Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PTrana Meditama Metropolitan Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PTrana Meditama Metropolitan Tbk's Days Payable falls into.
PTrana Meditama Metropolitan Tbk Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a Days Payable of 53.50 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. This is near median its historical median of 51.90. Over the past decade, PTrana Meditama Metropolitan Tbk's Days Payable has ranged from 33.41 to 95.10. According to the industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #341 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 56.1%.
Is PTrana Meditama Metropolitan Tbk's Days Payable too high?
PTrana Meditama Metropolitan Tbk's current Days Payable of 53.50 is near median its 10-year median of 51.90. Over the past 10 years, this metric has ranged from a low of 33.41 to a high of 95.10. The Healthcare Providers & Services industry median Days Payable is 57.32. PTrana Meditama Metropolitan Tbk's value of 53.50 is 6.7% below this industry median. Based on the distribution chart, PTrana Meditama Metropolitan Tbk ranks #341 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PTrana Meditama Metropolitan Tbk ranks #341 out of 608 companies for Days Payable. This places PTrana Meditama Metropolitan Tbk in the lower half of its industry. The industry median Days Payable is 57.32. PTrana Meditama Metropolitan Tbk's value of 53.50 is 6.7% below this benchmark. Historically, PTrana Meditama Metropolitan Tbk's own Days Payable has ranged from 33.41 to 95.10 over the past decade. While the company's 10-year median is 51.90 vs. the industry median of 57.32, PTrana Meditama Metropolitan Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.32, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PTrana Meditama Metropolitan Tbk's current Days Payable of 53.50 is 6.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PTrana Meditama Metropolitan Tbk's current Days Payable is 53.50, which is near median its own 10-year median of 51.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp355.08, compared to a current price of Rp306.00 — trading 13.8% below its estimated fair value. The current Days Payable is 53.50, which is near median its 10-year median of 51.90 and 6.7% below the Healthcare Providers & Services industry median of 57.32. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current Days Payable is 53.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp306.00 is trading 13.8% below its estimated GF Value™ of Rp355.08.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.
Key valuation signals for ISX:SAME:
Days Payable: 53.50 (near median its 10-year median of 51.90)
GF Value™: Rp355.08 vs. price of Rp306.00 (13.8% below fair value)
Industry Position: 6.7% below the Healthcare Providers & Services median (#341 of 608)
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PTrana Meditama Metropolitan Tbk Business Description
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
79GF Score
Get the complete analysis for ISX:SAME
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
